ctrl K

AI Score

Unlock

Revelation Biosciences In... (REVB)

AI Score

Unlock

2.60

-0.03 (-1.14%)

At close: Apr 01, 2025, 3:51 PM

2.63

1.18%

After-hours: Apr 01, 2025, 07:45 PM EDT

Revelation Biosciences Income Statement

Chart Mode

Year	FY24	FY23	FY22	FY21	FY20
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	25.05K	40.01K	69.17K	n/a
Gross Profit	n/a	-25.05K	-40.01K	-69.17K	n/a
Operating Income	-7.98B	-8.66M	-10.86M	-11.95M	-145.49K
Interest Income	n/a	n/a	n/a	n/a	10.91K
Pretax Income	-15.04B	-120.25K	-10.83M	-11.99M	-1.63M
Net Income	-15.04B	-120.25K	-10.79M	-11.99M	-1.63M
Selling & General & Admin	4.43B	4.51M	5.49M	5.04M	145.49K
Research & Development	3.55B	4.15M	5.38M	6.91M	2.56M
Other Expenses	n/a	n/a	34.96K	-36.35K	n/a
Operating Expenses	7.98B	8.66M	10.86M	11.95M	145.49K
Interest Expense	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	144.26K
Cost & Expenses	n/a	8.66M	10.86M	11.95M	145.49K
Income Tax	n/a	n/a	-34.96K	-219.78K	-3.8K
Shares Outstanding (Basic)	1.72M	228K	17.97K	9.4K	8.66K
Shares Outstanding (Diluted)	1.72M	228.64K	17.97K	9.4K	8.66K
EPS (Basic)	-8.77K	-0.53	-600.77	-1.28K	-188.18
EPS (Diluted)	n/a	n/a	n/a	n/a	n/a
EBITDA	-7.98B	-95.21K	-10.84M	-11.93M	-145.49K
Depreciation & Amortization	n/a	25.05K	40.01K	69.17K	3.8M